Skip to content
Screener

Vivani Medical VANI Q2 2026 earnings

Reported August 13, 2026 · After market close

EPS-$0.07Beat by $0.01
EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.07

Financials

Q2 2026

Income statement

See full
Operating income-$6.9M+7.9%
Net income-$6.4M+10.8%
EPS (diluted)-$0.07+41.7%

Balance sheet

See full
Cash & equivalents$18.6M+221%
Total debt$17.9M-4.1%
Total equity$19.0M+286%
Total assets$41.6M+44.1%

Cash flow

See full
Operating cash flow-$6.0M+0.9%
CapEx$99.0K+39.4%
Free cash flow-$6.1M+0.4%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$110.05M+28.1%
Enterprise value$109.27M+10.7%

Returns & leverage

See full
Return on equity-220.4%+69.6pp
Debt / equity0.9×-2.8×
Current ratio3.2×+2.0×

FAQ

When did Vivani Medical report Q2 2026 earnings?
Vivani Medical (VANI) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Vivani Medical's Q2 2026 revenue and EPS?
Vivani Medical reported eps of $-0.07 for Q2 2026.
Did Vivani Medical beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.08 by $0.01.
How did Vivani Medical's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 41.7% from $-0.12.
Where can I find Vivani Medical's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001753926-26-001482) and the 10-Q periodic report (0001753926-26-001477) directly on SEC EDGAR. The filing index links above go to sec.gov.